6. R.J. Forsyth, V. Van Nostrand, and G. Martin, "Visible-Residue Limit for Cleaning Validation and its Potential Application
in a Pharmaceutical Research Facility," Pharm. Technol.
28 (10), 58–72 (2004).
7. R.J. Forsyth and V. Van Nostrand, "The Use of Visible-Residue Limit for Introduction of New Compounds in a Pharmaceutical
Research Facility," Pharm. Technol.
29 (4), 134–140 (2005).
8. G.L. Fourman and M.V. Mullen, "Determining Cleaning Validation Acceptance Limits for Pharmaceutical Manufacturing Operations,"
Pharm. Technol.
17 (4), 54–60 (1993).
9. K.M. Jenkins and A.J. Vanderwielen, "Cleaning Validation: An Overall Perspective," Pharm. Technol.
18 (4), 60–73 (1994).
10. D.A. LeBlanc, D.D. Danforth, and J.M. Smith, "Cleaning Technology for Pharmaceutical Manufacturing," Pharm. Technol.
17 (10), 118–124 (1993).
Appendix
The complete article, tables, and appendix are available on
http://www.pharmtech.com/. Coming Soon.
|
